Paxlovid comes with a host of contraindications and costs $1561 for a 5- day course. Metformin costs $1/day and reduces viral ...

USA: A recent comparative study has uncovered promising evidence that GLP-1 receptor agonists may offer significant ocular ...

USA: A recent study published online in Surgery highlights that lung ultrasound may underdiagnose clinically significant ...

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ...

While several factors predict sustained glycemic control, predictors of sustained weight control with tirzepatide appear ...

Pharmaceuticals containing a probable carcinogen have captured the FDA's attention, and Crystal Lake drug packaging maker ...

GLP-1 agonists, widely used for obesity and diabetes management, have been associated with a reduced risk of most ...

Alzheimer’s disease currently has no cure. Treatment focuses on managing symptoms and improving quality of life. Medications, ...

In an interview with Peers & Perspectives in Oncology, Sherry Shen, MD, discusses the GLP-1 agonists analyzed for weight ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.